Home Stocks Mankind Pharma Ltd

Mankind Pharma Ltd

The live share price of Mankind Pharma Ltd (MANKIND) as on 19 Apr 10:28am is ₹2,337.45 from NSE/BSE.

MANKIND NSE

₹2,337.45 ▼-2.43% (-58.2)

As on Apr 19, 2024 03:58 PM IST

How do you feel today about Mankind Pharma Ltd?

Key Metrics

PE Ratio

54.22

PB Ratio

12.28

Dividend Yield

-

Sector PB

5.82

Sector PE

51.18

Sector Div Yld

0.57%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Largecap, ₹93,635 Cr

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

The following charts display the financial performance of the Mankind Pharma Ltd (MANKIND) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Mankind Pharma Ltd (MANKIND), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Largecap, ₹93,635 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 8,890 Cr +11.24%
Operating Expense 580 Cr -371.09%
Net Income 1,281 Cr -10.58%
Net Profit Margin 14.42% -19.62%
Earning Per Share 32 -10.58%
EBITDA 2,042 Cr -7.18%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 1,528 Cr +19.39%
Total Assets 9,685 Cr +6.34%
Total Liabilities 2,062 Cr -26.14%
Total Equity 7,623 Cr +20.69%
Shares Outstanding 40.06 Cr -
Price to Book - -
Return on Assets 13.64% -26.39%
Return on Capital 22.52 Cr -30.08%

Cash Flows

(INR) Y/Y Change
Net Income 1,281 Cr -10.58%
Cash from Operations 1,813 Cr +97.14%
Cash from Investing -1,051 Cr -23.15%
Cash from Financing -739 Cr -222.35%
Net Change in Cash 21 Cr -86.03%
Free Cash Flow 981 Cr -168.82%
Total Promoter Holding
74.88%
Unpledged
Foreign Institutions
9.87%
Foreign Institutions
Retail & Others
4.11%
Retail & Others
Other Parties
Other Domestic Institutions
2.57%
Insurance Firms
Others
Mutual Funds
8.57%
Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

41.02

1Y Return

▲52.97%

CIPLA

Cipla Ltd

PE Ratio

29.3

1Y Return

▲47.58%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

18.93

1Y Return

▲21.05%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

31.2

1Y Return

▲78.33%

FAQs on Mankind Pharma Ltd

How to buy Mankind Pharma Ltd stocks?

You can easily buy the stocks/shares of Mankind Pharma Ltd (MANKIND) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Mankind Pharma Ltd?

The stock price of Mankind Pharma Ltd as on 19 Apr 2024 is ₹2,337.45

What is the 52-week High and Low of Mankind Pharma Ltd?

The 52-week high and low of Mankind Pharma Ltd (MANKIND) is ₹2,420 and ₹1,242.

What is the PE and PB ratio of Mankind Pharma Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Mankind Pharma Ltd are 54.22 and 12.28 respectively.

What are the peers or stocks similar to Mankind Pharma Ltd?

The peers or stocks similar to Mankind Pharma Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Mankind Pharma Ltd belong to?

Mankind Pharma Ltd (MANKIND) belongs to the Pharmaceuticals sector.

What is the Market Cap of Mankind Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mankind Pharma Ltd (MANKIND) is ₹93,635 Cr as of 19 Apr 2024

Can't decide whether or not to buy Mankind Pharma Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.